BCG-unresponsive high-grade non-muscle invasive bladder cancer: what does the practicing urologist need to know?

por Lebacle, Cedric, Loriot, Yohann, Irani, Jacques
Publicado 2021

Erdafitinib for locally advanced or metastatic urothelial carcinoma

por Siefker-Radtke, Arlene O, Loriot, Yohann
Publicado 2022

ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer

por Fizazi, Karim, Albiges, Laurence, Loriot, Yohann, Massard, Christophe
Publicado 2015

Adjustments in the Use of Intravesical Instillations of Bacillus Calmette-Guérin for High-risk Non-muscle-invasive Bladder Cancer During the COVID-19 Pandemic

por Lenfant, Louis, Seisen, Thomas, Loriot, Yohann, Rouprêt, Morgan
Publicado 2020

Lymphadenectomy for Upper Tract Urothelial Carcinoma: A Systematic Review

por Duquesne, Igor, Ouzaid, Idir, Loriot, Yohann, Moschini, Marco, Xylinas, Evanguelos
Publicado 2019

Lung Cancer Stem Cell: New Insights on Experimental Models and Preclinical Data

por Rivera, Caroline, Rivera, Sofia, Loriot, Yohann, Vozenin, Marie-Catherine, Deutsch, Eric
Publicado 2011

Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients

por Cabel, Luc, Loir, Elika, Gravis, Gwenaelle, Lavaud, Pernelle, Massard, Christophe, Albiges, Laurence, Baciarello, Giulia, Loriot, Yohann, Fizazi, Karim
Publicado 2017

Abiraterone Alone or in Combination With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Rising Prostate-Specific Antigen During Enzalutamide Treatment

por Attard, Gerhardt, Borre, Michael, Gurney, Howard, Loriot, Yohann, Andresen-Daniil, Corina, Kalleda, Ranjith, Pham, Trinh, Taplin, Mary-Ellen
Publicado 2018

Twitter as a Medical Media Among French Young Oncologists: Results from a National Survey

por Roulleaux Dugage, Matthieu, Naoun, Natacha, Bommier, Côme, Michalet, Morgan, Loriot, Yohann, Blanchard, Pierre, Hilmi, Marc, Soria, Jean-Charles
Publicado 2021

Bioluminescent Orthotopic Mouse Models of Human Localized Non-Small Cell Lung Cancer: Feasibility and Identification of Circulating Tumour Cells

por Mordant, Pierre, Loriot, Yohann, Lahon, Benoit, Castier, Yves, Lesèche, Guy, Soria, Jean-Charles, Vozenin, Marie-Catherine, Decraene, Charles, Deutsch, Eric
Publicado 2011

Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer

por Lavaud, Pernelle, Dumont, Clément, Thibault, Constance, Albiges, Laurence, Baciarello, Giulia, Colomba, Emeline, Flippot, Ronan, Fuerea, Alina, Loriot, Yohann, Fizazi, Karim
Publicado 2020

Ultrasound and Magnetic Resonance Imaging of Burned-Out Testicular Tumours: The Diagnostic Keys Based on 48 Cases

por Desmousseaux, Thomas, Arama, Emmanuel, Maxwell, Florian, Ferlicot, Sophie, Hani, Chahinez, Fizazi, Karim, Lebacle, Cédric, Loriot, Yohann, Boumerzoug, Meriem, Cohen, Julian, Garrouche, Nada, Rocher, Laurence
Publicado 2022

Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAI...

por Devlin, Nancy, Herdman, Michael, Pavesi, Marco, Phung, De, Naidoo, Shevani, Beer, Tomasz M., Tombal, Bertrand, Loriot, Yohann, Ivanescu, Cristina, Parli, Teresa, Balk, Mark, Holmstrom, Stefan
Publicado 2017

Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis

por Al Nakouzi, Nader, Wang, Chris Kedong, Beraldi, Eliana, Jager, Wolfgang, Ettinger, Susan, Fazli, Ladan, Nappi, Lucia, Bishop, Jennifer, Zhang, Fan, Chauchereau, Anne, Loriot, Yohann, Gleave, Martin
Publicado 2016

Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castrationresistant prostate cancer: a report from the PETRUS prospecti...

por Massard, Christophe, Oulhen, Marianne, Le Moulec, Sylvestre, Auger, Nathalie, Foulon, Stéphanie, Abou-Lovergne, Aurélie, Billiot, Fanny, Valent, Alexander, Marty, Virginie, Loriot, Yohann, Fizazi, Karim, Vielh, Philippe, Farace, Francoise
Publicado 2016

The Impact of Enzalutamide on the Prostate Cancer Patient Experience: A Summary Review of Health-Related Quality of Life across Pivotal Clinical Trials

por Tombal, Bertrand, Stenzl, Arnulf, Cella, David, Loriot, Yohann, Armstrong, Andrew J., Fizazi, Karim, Beer, Tomasz, Sternberg, Cora N., Hussain, Maha, Ivanescu, Cristina, Ganguli, Arijit, Ramaswamy, Krishnan, Saad, Fred
Publicado 2021

The Role of CT in the Staging and Follow-Up of Testicular Tumors: Baseline, Recurrence and Pitfalls

por Pierre, Thibaut, Selhane, Fatine, Zareski, Elise, Garcia, Camilo, Fizazi, Karim, Loriot, Yohann, Patrikidou, Anna, Naoun, Natacha, Bernard-Tessier, Alice, Baumert, Hervé, Lebacle, Cédric, Blanchard, Pierre, Rocher, Laurence, Balleyguier, Corinne
Publicado 2022

Outcomes of Patients with Advanced Urothelial Carcinoma after Anti–programmed Death-(ligand) 1 Therapy by Fibroblast Growth Factor Receptor Gene Alteration Status: An Observational...

por Rezazadeh Kalebasty, Arash, Benjamin, David J., Loriot, Yohann, Papantoniou, Dimitrios, Siefker-Radtke, Arlene O., Necchi, Andrea, Naini, Vahid, Carcione, Jenna Cody, Santiago-Walker, Ademi, Triantos, Spyros, Burgess, Earle F.
Publicado 2022

New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors

por Bamias, Aristotelis, Merseburger, Axel, Loriot, Yohann, James, Nicholas, Choy, Ernest, Castellano, Daniel, Lopez-Rios, F, Calabrò, Fabio, Kramer, Mario, de Velasco, Guillermo, Zakopoulou, Roubini, Tzannis, Kimon, Sternberg, Cora N
Publicado 2023

Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study

por Epaillard, Nicolas, Parent, Pauline, Loriot, Yohann, Lavaud, Pernelle, Vera-Cea, E-B., Martinez-Chanza, Nieves, Rodriguez-Vida, Alejo, Dumont, Clement, Lozano, Rebeca, Llácer, Casilda, Ratta, Raffaele, Oudard, Stephane, Thibault, Constance, Auclin, Edouard
Publicado 2021